Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Emblem Corp EMMBF

"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."

OTCPK:EMMBF - Post Discussion

Emblem Corp > With ALEF climbing like it is....
View:
Post by 82Supra on Jan 11, 2019 9:12am

With ALEF climbing like it is....

might turn out to be a not bad deal.  I'm sitting on 1.60 EMC entry and wih ALEF climbing, I could see my return.
What are other share holders expecting for a fair price for EMC?
Comment by Stiltskin on Jan 11, 2019 9:19am
This post has been removed in accordance with Community Policy
Comment by DoItRight on Jan 11, 2019 9:37am
LINK TO NEW ARTICLE
Comment by Kornooto on Jan 11, 2019 10:28am
With alefa at 1.67 right now EMC should be 1.38 witht he deal.
Comment by Mamalikespie on Jan 11, 2019 12:12pm
I see the price should be around, 1.5 - 2. If the ALEF deal wasn't a thing, I would have said that emblem should be going to 2-2.7 by Q2, just on sales. I was expecting them to miss their 80m sales target, but have minimum 40m in sales, which makes a forward P/S ratio of around 4, reasonable for this industry. This would be what they should be valued at by Q1, once they have demonstrated some ...more  
Comment by MrOptimization on Jan 11, 2019 2:30pm
I agree with this analysis. I see it being around 1.5-2 by end of Q2, and that the resistance barrier is at 1.21 until the vote is tallied. I'll likely get back in closer to vote day, so I can make money in the meantime. I just bought Aphria today, after doing a 1 day flip on Aurora Cannabis.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities